Stock PUR PURE BIOLOGICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Pure Biologics S.A. Share Price

Equities

PUR

PLPRBLG00010

Biotechnology & Medical Research

Market Closed - Warsaw S.E.
Other stock markets
 09:25:42 14/05/2024 pm IST 		5-day change 1st Jan Change
7.41 PLN +1.51% Intraday chart for Pure Biologics S.A. +0.14% -41.38%
2023 Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2021 3L 64.45T 53.82L Sales 2022 7L 2L 1.4Cr Capitalization 5.18Cr 1.32Cr 109.84Cr
Net income 2021 -1.1Cr -27.91L -23Cr Net income 2022 -2.5Cr -63.44L -53Cr EV / Sales 2021 573 x
Net cash position 2021 2.98Cr 75.66L 63Cr Net cash position 2022 43.17L 10.95L 9.15Cr EV / Sales 2022 71.8 x
P/E ratio 2021
-14.7 x
P/E ratio 2022
-2 x
Employees 96
Yield 2021 *
-
Yield 2022
-
Free-Float 85.51%
More Fundamentals * Assessed data

Chart Pure Biologics S.A.

Dynamic Chart

Latest news about Pure Biologics S.A.

Pure Biologics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Pure Biologics S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Presage Announces Collaboration with Pure Biologics to Investigate Oncology Agents in Early Development with CIVO® Technology CI
Dom Maklerski Navigator S.A. and IPOPEMA Securities S.A. agreed to acquire an unknown minority stake in Pure Biologics Spólka Akcyjna. CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Pure Biologics Sp?lka Akcyjna Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Pure Biologics Spólka Akcyjna Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Pure Biologics Spólka Akcyjna announced that it has received €6.7 million in funding from National Centre for Research and Development CI
Pure Biologics Spólka Akcyjna announced that it has received PLN 10.1 million in funding CI
More news

Quotes and Performance

1 day+1.51%
1 week+0.14%
Current month-5.61%
1 month-10.72%
3 months-25.00%
6 months-32.64%
Current year-41.38%
More quotes

Highs and lows

1 week
7.12
Extreme 7.12
7.69
1 month
7.11
Extreme 7.11
8.40
Current year
6.95
Extreme 6.95
16.98
1 year
5.01
Extreme 5.01
21.90
3 years
5.01
Extreme 5.01
118.60
5 years
5.01
Extreme 5.01
152.00
10 years
5.01
Extreme 5.01
152.00
More quotes

Managers and Directors - Pure Biologics S.A.

Managers TitleAgeSince
Maciej Piotr Mazurek FOU
 Founder - 01/10/01
Filip Jan Jelen CEO
 Chief Executive Officer 47 01/10/01
Romuald Harwas DFI
 Director of Finance/CFO 52 16/19/16
Members of the board TitleAgeSince
Tadeusz Wesolowski BRD
 Director/Board Member 72 07/19/07
Andrzej Jan Trznadel FOU
 Founder 62 01/10/01
Pawel Marcin Wisniewski BRD
 Director/Board Member 44 26/23/26
More insiders

Quotes

Date Price Change Volume
14/24/14 7.41 +1.51% 14,846
13/24/13 7.3 +0.69% 11,853
10/24/10 7.25 +0.28% 9,574
09/24/09 7.23 -0.96% 3,136
08/24/08 7.3 -1.35% 14,096

Delayed Quote Warsaw S.E., May 14, 2024 at 09:25 pm IST

More quotes

Company Profile

Pure Biologics SA is a manufacturer of biological products. The Company was founded in August 2010 and is located in Wroclaw, Poland.
Sector
Biotechnology & Medical Research
More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PURE BIOLOGICS S.A. Stock Pure Biologics S.A.
-41.38% 61.18L
MODERNA, INC. Stock Moderna, Inc.
+29.03% 4.82TCr
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.10% 4.17TCr
LONZA GROUP AG Stock Lonza Group AG
+43.45% 4.1TCr
CELLTRION, INC. Stock Celltrion, Inc.
-5.26% 2.88TCr
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.48% 2.56TCr
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.74% 1.9TCr
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+9.06% 1.29TCr
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.01% 1.2TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.51% 1.18TCr
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PUR Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW